2023
DOI: 10.1590/1806-9282.20230465
|View full text |Cite
|
Sign up to set email alerts
|

A vignette epexegesis of a model for training sonography-guided fine-needle aspirations in thyroidology and thyroidologists: think twice with needle size?

Demet Sengul,
Ilker Sengul
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

2
0

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 8 publications
(16 reference statements)
0
2
0
Order By: Relevance
“…Debate is still ongoing on an optimal needle size for thyroid FNA cytology in thyroidology. In this sense, we reported a favorable non-diagnostic cytology rate on a sum of 500 nodules in 425 eligible consecutive outpatients during 38 months, involving ultrasonography (US)-guided FNA with a surgeon-performed US (SUS) in thyroid nodules with 27-G fine needles [5][6][7][8][9][10][11][12] . Therefore, would the outcomes of the study at that point be altered as they had harnessed significantly (i) finer or (ii) larger needle sizes?…”
Section: Re: "American Thyroid Association and Thyroid Imaging Report...mentioning
confidence: 99%
“…Debate is still ongoing on an optimal needle size for thyroid FNA cytology in thyroidology. In this sense, we reported a favorable non-diagnostic cytology rate on a sum of 500 nodules in 425 eligible consecutive outpatients during 38 months, involving ultrasonography (US)-guided FNA with a surgeon-performed US (SUS) in thyroid nodules with 27-G fine needles [5][6][7][8][9][10][11][12] . Therefore, would the outcomes of the study at that point be altered as they had harnessed significantly (i) finer or (ii) larger needle sizes?…”
Section: Re: "American Thyroid Association and Thyroid Imaging Report...mentioning
confidence: 99%
“…Nevertheless, at least a minimal debate is still ongoing on an accurate decision on N/L whether it is a biomarker in discrimination of malignity or not. Exempligratia, we reported that N/L was not a convenient and favorable biomarker in forecasting thyroid malignancy 18 in thyroidology [19][20][21][22][23][24][25][26][27][28][29] . Of note, N/L, particularly in the thyroid with head and neck providers, the growing spectrum of clinical management for challenging conditions remains, especially for thyroidologists and thyroid health as different peas in a pod.…”
mentioning
confidence: 99%